CN118843638A - Crf2受体激动剂及其在治疗中的用途 - Google Patents

Crf2受体激动剂及其在治疗中的用途 Download PDF

Info

Publication number
CN118843638A
CN118843638A CN202380019995.3A CN202380019995A CN118843638A CN 118843638 A CN118843638 A CN 118843638A CN 202380019995 A CN202380019995 A CN 202380019995A CN 118843638 A CN118843638 A CN 118843638A
Authority
CN
China
Prior art keywords
acid
gglu
amino
cooh
valine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380019995.3A
Other languages
English (en)
Chinese (zh)
Inventor
P·扎尼科
M-L·奥责奥克斯
D·罗沃思
E·比安基
M·特利佩皮
A·桑托普雷特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korteri Pharmaceutical Co
Original Assignee
Korteri Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korteri Pharmaceutical Co filed Critical Korteri Pharmaceutical Co
Publication of CN118843638A publication Critical patent/CN118843638A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Immunology (AREA)
CN202380019995.3A 2022-02-23 2023-02-21 Crf2受体激动剂及其在治疗中的用途 Pending CN118843638A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158188.7A EP4234574A1 (en) 2022-02-23 2022-02-23 Crf2 receptor agonists and their use in therapy
EP22158188.7 2022-02-23
PCT/EP2023/054317 WO2023161229A1 (en) 2022-02-23 2023-02-21 Crf2 receptor agonists and their use in therapy

Publications (1)

Publication Number Publication Date
CN118843638A true CN118843638A (zh) 2024-10-25

Family

ID=80819682

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380019995.3A Pending CN118843638A (zh) 2022-02-23 2023-02-21 Crf2受体激动剂及其在治疗中的用途

Country Status (15)

Country Link
US (1) US20260001928A1 (cg-RX-API-DMAC10.html)
EP (3) EP4234574A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025508820A (cg-RX-API-DMAC10.html)
KR (1) KR20240153565A (cg-RX-API-DMAC10.html)
CN (1) CN118843638A (cg-RX-API-DMAC10.html)
AU (1) AU2023224327A1 (cg-RX-API-DMAC10.html)
CA (1) CA3247142A1 (cg-RX-API-DMAC10.html)
ES (1) ES3063881T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260115T1 (cg-RX-API-DMAC10.html)
IL (1) IL314055A (cg-RX-API-DMAC10.html)
IS (1) IS050770A (cg-RX-API-DMAC10.html)
MX (1) MX2024010296A (cg-RX-API-DMAC10.html)
PL (1) PL4482578T3 (cg-RX-API-DMAC10.html)
WO (1) WO2023161229A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202406196B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260089954A (ko) * 2023-11-17 2026-06-16 구브라 에이/에스 hCRHR2 선택적 폴리펩타이드
WO2026064495A1 (en) * 2024-09-20 2026-03-26 Neurocrine Biosciences, Inc. Chemically modified peptides and use thereof
WO2026064486A1 (en) * 2024-09-20 2026-03-26 Neurocrine Biosciences, Inc. Chemically modified peptides and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2114437A2 (en) * 2006-10-16 2009-11-11 ConjuChem Biotechnologies Inc. Modified corticotropin releasing factor peptides and uses thereof
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
WO2019140030A1 (en) * 2018-01-12 2019-07-18 Eli Lilly And Company Combination therapy
US12679878B2 (en) * 2020-08-19 2026-07-14 Sanofi CRF2 receptor agonists and their use in therapy

Also Published As

Publication number Publication date
EP4482578C0 (en) 2025-12-24
CA3247142A1 (en) 2023-08-31
EP4482578A1 (en) 2025-01-01
IL314055A (en) 2024-09-01
WO2023161229A1 (en) 2023-08-31
AU2023224327A1 (en) 2024-08-29
EP4482578B1 (en) 2025-12-24
EP4781998A2 (en) 2026-07-29
MX2024010296A (es) 2024-09-18
JP2025508820A (ja) 2025-04-10
IS050770A (is) 2024-10-15
KR20240153565A (ko) 2024-10-23
HRP20260115T1 (hr) 2026-03-13
ZA202406196B (en) 2025-03-26
ES3063881T3 (en) 2026-04-21
EP4234574A1 (en) 2023-08-30
PL4482578T3 (pl) 2026-03-16
US20260001928A1 (en) 2026-01-01

Similar Documents

Publication Publication Date Title
KR102440323B1 (ko) 인크레틴 유사체 및 그의 용도
CN111491658B (zh) 肠促胰岛素类似物及其用途
US8450266B2 (en) Analogues of glucose-dependent insulinotropic polypeptide
JP7832927B2 (ja) Crf2受容体アゴニスト及び治療におけるその使用
US20110136733A1 (en) Analogues of glucose-dependent insulinotropic polypeptide
EP4482578B1 (en) Crf2 receptor agonists and their use in therapy
JP2023078367A (ja) 新規glp-1類似体
CN114787183A (zh) 肠促胰岛素类似物及其用途
KR20150003910A (ko) Gip-glp-1 이원 작용제 화합물 및 방법
CN102596228A (zh) 神经肽-2受体(y-2r)激动剂
AU2024215381A1 (en) Gip/glp1/gcg tri-receptor agonists and uses thereof
HK40112064A (en) Crf2 receptor agonists and their use in therapy
HK40095414A (en) Crf2 receptor agonists and their use in therapy
RU2845766C1 (ru) Агонисты рецептора crf2 и их применение в терапии
WO2024213022A1 (zh) 肠促胰素类似物及其制备方法和应用
KR20260022948A (ko) Glp-1/gip 이중 수용체 작용제, glp-1/gcg 이중 수용체 작용제, 및 glp-1/gip/gcg 삼중 수용체 작용제
HK40087027B (en) Crf2 receptor agonists and their use in therapy
HK40087027A (en) Crf2 receptor agonists and their use in therapy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40112064

Country of ref document: HK